InsidersTradesSigma
Follow the 恒瑞医药 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 恒瑞医药 has published 2 reports. Market capitalisation: €354.8bn. The latest transaction was reported on 2 September 2025 (Sale). Among the most active insiders: 孙杰平. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
恒瑞医药 es una empresa china especializada en el sector de la salud y farmacéutico. Cotiza en la Bolsa de Shanghái (XSHG).